Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Signal transduction inhibitor].

Y Ueda1, N Saijo

  • 1Medical Oncology Division, National Cancer Center Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 2001
PubMed
Summary

New target-based cancer drugs, including signal transduction inhibitors, show promise in clinical trials. Further research is needed for their effective clinical evaluation and integration into chemotherapy regimens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.

British journal of cancer·2011
Same author

Cross-resistance to antineoplastic agents in a human small-cell lung-cancer subline resistant to okadaic Acid.

Oncology reports·2011
Same author

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

Oncogene·2011
Same author

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606).

British journal of cancer·2010

Area of Science:

  • Molecular biology and cancer research.
  • Development of novel anticancer therapeutics.

Context:

  • Advances in molecular biology have identified numerous cancer targets.
  • New drug categories like target-based, non-cytotoxic, and cytostatic drugs have emerged.
  • Signal transduction pathways are crucial for cellular responses and cancer development.

Purpose:

  • To introduce signal transduction inhibitors as a new class of anticancer drugs.
  • To highlight the role of these inhibitors in cancer chemotherapy.
  • To emphasize the need for rigorous clinical evaluation of these non-cytotoxic agents.

Summary:

  • Signal transduction inhibitors target key molecules in cellular signaling cascades, such as Ras and MAPK pathways.
  • These inhibitors, including Ras, protein kinase C, and MAPK cascade inhibitors, have demonstrated antitumor effects in clinical trials.
  • Unlike traditional cytotoxic drugs, these agents exert non-cytotoxic effects.

Impact:

  • Signal transduction inhibitors are poised to play a significant role in future cancer chemotherapy.
  • Efficient clinical evaluation is essential to optimize the use of these novel therapies.
  • Future research on signal transduction inhibitors holds potential for improved cancer treatment outcomes.

Related Experiment Videos